Correlation Between Bristol Myers and Novartis
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Novartis AG ADR, you can compare the effects of market volatilities on Bristol Myers and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Novartis.
Diversification Opportunities for Bristol Myers and Novartis
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bristol and Novartis is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Bristol Myers i.e., Bristol Myers and Novartis go up and down completely randomly.
Pair Corralation between Bristol Myers and Novartis
Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Novartis. In addition to that, Bristol Myers is 1.19 times more volatile than Novartis AG ADR. It trades about -0.17 of its total potential returns per unit of risk. Novartis AG ADR is currently generating about -0.07 per unit of volatility. If you would invest 9,605 in Novartis AG ADR on January 20, 2024 and sell it today you would lose (169.00) from holding Novartis AG ADR or give up 1.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Novartis AG ADR
Performance |
| Timeline |
| Bristol Myers Squibb |
| Novartis AG ADR |
Bristol Myers and Novartis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Novartis
The main advantage of trading using opposite Bristol Myers and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.| Bristol Myers vs. Alkermes Plc | Bristol Myers vs. Ironwood Pharmaceuticals | Bristol Myers vs. Deciphera Pharmaceuticals LLC | Bristol Myers vs. Eagle Pharmaceuticals |
| Novartis vs. Alkermes Plc | Novartis vs. Ironwood Pharmaceuticals | Novartis vs. Deciphera Pharmaceuticals LLC | Novartis vs. Eagle Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |